Results
|
|
1.
|
|
|
|
2.
|
|
|
|
3.
|
Unraveling the molecular mechanism of BNC105, a phase II clinical trial vascular disrupting agent, provides insights into drug design. [electronic resource] by
- Wang, Tao
- Wu, Chengyong
- Wang, Chengdi
- Zhang, Guiping
- Arnst, Kinsie E
- Yao, Yijun
- Zhang, Zhixiong
- Wang, Yuxi
- Pu, Dan
- Li, Weimin
Publication details: Biochemical and biophysical research communications Feb 2020
In:
Biochemical and biophysical research communications
Availability: No items available.
|
|
|
4.
|
Molecular mechanism of crolibulin in complex with tubulin provides a rationale for drug design. [electronic resource] by
- Zhang, Zhixiong
- Wang, Chengdi
- Ma, Lingling
- Jiang, Xiaohua
- Wu, Chengyong
- Wang, Yanyan
- Jiang, Yuting
- Zheng, Wenyue
- Yang, Yang
- Ma, Yuxing
- Yang, Jinliang
Producer: 20191216
In:
Biochemical and biophysical research communications vol. 511
Availability: No items available.
|
|
|
5.
|
Discovery of Pyrrolo[3,2- d]pyrimidin-4-one Derivatives as a New Class of Potent and Cell-Active Inhibitors of P300/CBP-Associated Factor Bromodomain. [electronic resource] by
- Huang, Luyi
- Li, Hui
- Li, Linli
- Niu, Lu
- Seupel, Raina
- Wu, Chengyong
- Cheng, Wei
- Chen, Chong
- Ding, Bisen
- Brennan, Paul E
- Yang, Shengyong
Producer: 20200622
In:
Journal of medicinal chemistry vol. 62
Availability: No items available.
|
|
|
6.
|
((S)-3-Mercapto-2-methylpropanamido)acetic acid derivatives as metallo-β-lactamase inhibitors: Synthesis, kinetic and crystallographic studies. [electronic resource] by
- Liu, Sha
- Jing, Li
- Yu, Zhu-Jun
- Wu, Chengyong
- Zheng, Yongxiang
- Zhang, En
- Chen, Qiang
- Yu, Yamei
- Guo, Li
- Wu, Yong
- Li, Guo-Bo
Producer: 20180302
In:
European journal of medicinal chemistry vol. 145
Availability: No items available.
|
|
|
7.
|
Mechanism of microtubule stabilization by taccalonolide AJ. [electronic resource] by
- Wang, Yuxi
- Yu, Yamei
- Li, Guo-Bo
- Li, Shu-Ang
- Wu, Chengyong
- Gigant, Benoît
- Qin, Wenming
- Chen, Hao
- Wu, Yangping
- Chen, Qiang
- Yang, Jinliang
Producer: 20181218
In:
Nature communications vol. 8
Availability: No items available.
|
|
|
8.
|
The bromodomain protein BRD4 positively regulates necroptosis via modulating MLKL expression. [electronic resource] by
- Xiong, Yu
- Li, Linli
- Zhang, Liting
- Cui, Yangyang
- Wu, Chengyong
- Li, Hui
- Chen, Kai
- Yang, Qiuyuan
- Xiang, Rong
- Hu, Yiguo
- Huang, Shile
- Wei, Yuquan
- Yang, Shengyong
Producer: 20200928
In:
Cell death and differentiation vol. 26
Availability: No items available.
|
|
|
9.
|
X-ray crystal structure guided discovery of new selective, substrate-mimicking sirtuin 2 inhibitors that exhibit activities against non-small cell lung cancer cells. [electronic resource] by
- Yang, Ling-Ling
- Wang, Hua-Li
- Zhong, Lei
- Yuan, Chen
- Liu, Si-Yu
- Yu, Zhu-Jun
- Liu, Sha
- Yan, Yu-Hang
- Wu, Chengyong
- Wang, Yuxi
- Wang, Zhouyu
- Yu, Yamei
- Chen, Qiang
- Li, Guo-Bo
Producer: 20180807
In:
European journal of medicinal chemistry vol. 155
Availability: No items available.
|
|
|
10.
|
Structure-Based Development of (1-(3'-Mercaptopropanamido)methyl)boronic Acid Derived Broad-Spectrum, Dual-Action Inhibitors of Metallo- and Serine-β-lactamases. [electronic resource] by
- Wang, Yao-Ling
- Liu, Sha
- Yu, Zhu-Jun
- Lei, Yuan
- Huang, Meng-Yi
- Yan, Yu-Hang
- Ma, Qiang
- Zheng, Yang
- Deng, Hui
- Sun, Ying
- Wu, Chengyong
- Yu, Yamei
- Chen, Qiang
- Wang, Zhenling
- Wu, Yong
- Li, Guo-Bo
Producer: 20200610
In:
Journal of medicinal chemistry vol. 62
Availability: No items available.
|